Pharmaceutical News

The pharmaceutical industry will reap between $10 billion and $35 billion in additional profits over the next decade thanks to the Affordable Care Act, also known as Obamacare, a new analysis from London-based GlobalData shows.

Datameer gives Cardinal Health's business users the self-service tools they need to quickly and easily visualize and understand data to make meaningful decisions.

Impax Laboratories, Inc. today announced that the Company will present at the Deutsche Bank 38th Annual Health Care Conference on Thursday, May 30, at 12:00 p.m. Eastern Standard Time.

's stock had its "hold" rating restated by analysts at Independent Research GmbH in a research report issued to clients and investors on Friday, Analyst Ratings Network.com reports.

Drug Giants Such as Bayer AG , Pfizer Inc. , and Roche Accused of Shady Soviet-Era Drug Trials Staying up-to-date has never been simpler.

The pharmaceutical industry is one of the biggest industries in the world. Currently the global pharmaceutical industry is worth $300 billion a year, and expected to reach $400 billion in the coming few years.

The building at 673 Mohawk St. hasn't been used as a school since 1968. It hasn't made it as a commercial property.

A leading New Zealand pharmaceutical scientist has been lecturing University of Canterbury chemistry students and looking at collaborating with UC researchers.

MCK shareholders have witnessed a decrease in support from the world's most elite money managers of late.

Teva Pharmaceutical Industries Ltd was in 47 hedge funds' portfolio at the end of March.

Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating once a week MLN9708 in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are not candidates for transplant.

WASHINGTON, May 23, 2013 The mood is grim on Wall Street this morning after yesterday's double whammy.

's stock had its "neutral" rating reiterated by equities research analysts at BNP Paribas in a research note issued to investors on Thursday, Analyst Ratings.Net reports.

Shares of Bayer AG opened at 109.20 on Thursday. Bayer AG has a 52 week low of $59.57 and a 52 week high of $107.94. The stock's 50-day moving average is currently $103.1. The company has a market cap of $90.303 billion and a P/E ratio of 27.20. A number of other analysts have also recently weighed in on BAYRY.

The main reasons for growth for analytical instruments in China include flourishing pharmaceutical industry along with the increasing focus towards wastewater treatment.

Cardinal Health, Inc. Release: New Research Proves Clinical Pathways Can Reduce Cancer Care Costs and Improve Quality While Increasing Physician Reimbursement by 20201, many in the healthcare industry are looking for ways to curb that cost curve while maintaining quality of care for cancer patients and preserving fair compensation for physicians.

McKesson declared a quarterly dividend on Wednesday, May 22nd, AnalystRatingsNetwork reports.

Top US stock recommendations of the day: ADVANCED MICRO DEVICES: Jefferies & Co reiterates BUY rating.

Bridgeton-based KV Pharmaceutical reported a net loss of $3.5 million for the month ended April 30, on revenue of $8.3 million, according to a recent filing with the U.S. Securities and Exchange Commission .

A shortage of foreign currency has brought Syria's pharmaceutical industry production to a near halt, AFP has reported.